Researchers at Mount Sinai have developed the first fully human monoclonal antibody cocktail to provide complete protection against Nipah and Hendra viruses in preclinical models, offering a potential ...
A peptide vaccine targeting PCSK9 has demonstrated sustained antibody responses and reductions in LDL cholesterol and atherosclerotic plaque formation in animal models, offering a potential long-term ...
Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...
A commonly prescribed epilepsy drug has shown striking potential as a vaccine booster in a controlled human trial, more than ...
A biomechanical well plate inspired by the pressure-sensing lateral line of fish can wirelessly monitor the pulse of multiple ...
One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...
A new multiplex immunofluorescence workflow using standard laboratory equipment and open-source software enables detailed ...
South Korean researchers have developed an automated, modular cell-free protein synthesis platform that slashes preparation ...
From early research to quality control, maintaining analytical continuity is no easy task. Could a single sequencing workflow help simplify analytical assessment?
Researchers at the University of Michigan have assembled a database of more than 50,000 chemical experiments, offering AI ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results